United States· US:42023-269_a1b07822-805f-4c68-914f-1db1cead480a
PREVDUO
A medicinal product containing neostigmine methylsulfate; glycopyrrolate, registered in United States by Endo USA.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEOSTIGMINE METHYLSULFATE; GLYCOPYRROLATE
- Manufacturer
- Endo USA
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1142023-269-05
- ndc1142023269055 SYRINGE, PLASTIC in 1 CARTON (42023-269-05) / 3 mL in 1 SYRINGE, PLASTIC (42023-269-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neostigmine methylsulfate; glycopyrrolate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCopnegEQL Pharma AB
- IrelandGlycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per ml Solution for InjectionMercuryPharm Ltd
- NorwayCopnegEQL Pharma AB
- SwedenCopneg 0,5 mg/ml + 2,5 mg/ml Injektionsvätska, lösningEQL Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Combistig
- Belgium · Robinul-Neostigmine
- Denmark · Copneg, Robinul-Neostigmin
- Estonia · Glynex
- Finland · Copneg, Glycostigmin
- United Kingdom (Northern Ireland) · Glycopyrrolate And Neostigmine Metilsulfate Mercury Pharmaceuticals Ltd,, Glycopyrronium Bromide And Neostigmine Metilsulfate Martindale Pharmaceuticals
- Croatia · Novistig
- Hungary · Novistig
- Ireland · Glycopyrronium Bromide And Neostigmine Metilsulfate Mercurypharm, Novistig
- Luxembourg · Robinul-Neostigmine
- Norway · Copneg, Robinul-Neostigmin
- Poland · Novistig
- Sweden · Copneg, Robinul
- Slovenia · Novistig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e8457d1-d413-42a7-bc1f-d56db9d948d9 GET /v1/drugs/4e8457d1-d413-42a7-bc1f-d56db9d948d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "1; .2",
"substance": "NEOSTIGMINE METHYLSULFATE; GLYCOPYRROLATE",
"productndc": "42023-269",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "NDA216903",
"marketing_category": "NDA"
}See everything about neostigmine methylsulfate; glycopyrrolate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.